Escalation of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer: to whom, when and why?

• Autor Principal: I. V. Kolyadina (Author)
• Formato: Libro
• Publicado: ABV-press, 2024-05-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

This review presents the evolution of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer, describes late relapse phenomenon, provides clinical rationale for escalation of treatment, analyzes the key stages of the metastatic cascade, and provides a scientific rationale...